Cooper Companies (The) (COO): financials, SEC filings and peers
Cooper Companies (The) (COO) is a health care supplies company in the Health Care sector of the S&P 500, headquartered in San Ramon, California.
It was founded in 1958 and joined the S&P 500 on September 23, 2016.
Its fiscal year ends in October, and its shares trade on the Nasdaq.
In its SEC filings it is classified as “Ophthalmic Goods”.
Cooper Companies (The) at a glance
- Revenue (12 months)
- $4.2B
- Revenue growth
- +4.7%
- Operating margin
- 12.8%
- Net income (12 months)
- $570M
- Free cash flow (12 months)
- $678M
- Cash
- $155M
- Debt
- $3.2B
- Diluted EPS (12 months)
- $2.92
Twelve months to July 31, 2026, from the 10-Q filed September 9, 2026.
Latest twelve months
Over the twelve months to July 31, 2026, Cooper Companies (The) reported revenue of $4.2 billion, about the same as a year earlier (+4.7%).
Its operating margin was 12.8%, down 5.5 percentage points from a year earlier: for every $100 of sales, about $13 was left as operating profit.
Net income was $570 million (13.5% of revenue), 39.8% higher than a year earlier.
Operating cash flow was $1.0 billion and capital spending $355 million, leaving free cash flow of $678 million (16.0% of revenue).
At the end of the period it held $155 million in cash and $3.2 billion in debt, a net debt position of $3.0 billion.
The diluted share count fell 3.3% in a year, typically the result of buybacks.
Five-year trend
- Revenue went from $2.4 billion in fiscal 2020 to $4.1 billion in fiscal 2025, about 11.0% a year.
- Revenue has grown for 5 fiscal years in a row.
- Operating margin widened from 12.8% to 16.7% over the same years.
- Free cash flow was positive in each of the last 6 fiscal years.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.9B | $3.3B | $3.6B | $3.9B | $4.1B |
| Revenue growth | 20.2% | 13.2% | 8.6% | 8.4% | 5.1% |
| Operating margin | 17.3% | 15.3% | 14.8% | 18.1% | 16.7% |
| Net income | $2.9B | $386M | $294M | $392M | $375M |
| Free cash flow | $524M | $450M | $215M | $288M | $434M |
| Diluted EPS | $59.16 | $1.94 | $1.48 | $1.96 | $1.87 |
Fiscal years as reported in Cooper Companies (The)’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 10-Q filed September 9, 2026 — quarterly report
- 8-K filed September 9, 2026 — Earnings results; Other event
- 10-Q filed June 5, 2026 — quarterly report
- 8-K filed June 4, 2026 — Earnings results; Other event
- 8-K filed May 4, 2026 — Executive or director change
- 8-K filed April 8, 2026 — Shareholder vote results
- 10-Q filed March 6, 2026 — quarterly report
- 8-K filed March 5, 2026 — Earnings results
Companies like Cooper Companies (The)
Other S&P 500 companies in Health Care Supplies:
More from Health Care
Questions about Cooper Companies (The)
Is Cooper Companies (The)'s revenue growing?
Yes. Revenue for the twelve months to July 31, 2026 was $4.2 billion, up 4.7% from a year earlier, according to its SEC filings.
Is Cooper Companies (The) profitable?
Yes. It earned $570 million in net income over the twelve months to July 31, 2026, a net margin of 13.5%.
Does Cooper Companies (The) have more cash or more debt?
At July 31, 2026 it had $155 million in cash and $3.2 billion in debt, so more debt than cash.
When did Cooper Companies (The) last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on September 9, 2026.
Which companies are similar to Cooper Companies (The)?
In the S&P 500, Cooper Companies (The) is grouped in Health Care Supplies within the Health Care sector. Align Technology (ALGN), West Pharmaceutical Services (WST) are in the same group.
Understand the numbers
Source: Cooper Companies (The)’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.